By killing target cells, CD4 CTLs under pathologic conditions, which exhibit upregulated cytotoxic and proinflammatory molecules (e.g., granzyme, perforin, interferon-γ, etc.), are able to control tumor growth and viral infection as well as hasten the progression of autoimmune diseases [6, 7]. This evidence concerns the gene CD4 and neoplasm.